Iziphumo eziPhakathi, izilumkiso, ukusebenzisana
I-Cymbalta (duloxetine hydrochloride) yi- serotonin-norepinephrine reuptake inhibitor (i-SNRI) engathandabuzekiyo. Kuthathwa ngomlomo njengepilisi okanye i-capsule.
Imiqondiso kunye nokusetyenziswa
I-Cymbalta isetyenziselwa unyango lwe-disorder disorder. Ukusebenza kweCymbalta ukusetyenziswa kwexesha elide, okanye ngaphezu kweeveki ezisi-9, akuzange kuhlolwe ngokuchanekileyo kwiimvavanyo zeclini.
Kwakhona kusetyenziselwa ukulawulwa kweentlungu zesifo sikashukela se-neuropathic intlungu, i-fibromyalgia, ubuhlungu obungapheliyo kunye nesifo sengqondo kunye nokukhathazeka okuqhelekileyo.
Ukungqinelana
I-Cymbalta akufanele isetyenziswe ngabani na oye wabonisa uvelwano kwi-duloxetine okanye nayiphi na izithako ezingasebenzi ezingekho kwiCymbalta. Akufanele isetyenziswe ngexesha elifanayo njenge- monoamine oxidase inhibitor (i-MAOI) yokudandathelanisa. Kwiimvavanyo zesikliniki, i-Cymbalta yayidibaniswe nokunyusa i-mydriasis, ehluthwa ngumfundi welihlo, kwizigulane ezinokulawulwa kwe-glaucoma engancinci kwaye ayifanele isetyenziswe zizigulane ezile meko.
Ukuqapha
Kukho iingxelo zokungaphumeleli kwesibindi kwizigulane zisebenzisa i-Cymbalta. Kuye kwadibaniswa nokunyuka kwengcinezelo yegazi, ngoko ke uxinzelelo lwegazi kufuneka lubekwe iliso kulo lonke unyango. I-Cymbalta kufuneka isetyenziswe ngokulumkisa kwizigulane ezineembali ze-mania okanye i-seizures.
Akufanele isetyenziswe kulabo abaneglaucoma engancinciyo-angle. Kufuneka kupheliswe ngokuthe ngcembe ukukhusela iimpawu zokuyeka. Amava kunye neCymbalta kwizigulane ezinezinye izigulane.
Izilumkiso
Izigulane kufuneka zijongwe ngokukhawuleza ukuxinezeleka nokuzibulala, ngokukodwa ekuqaleni kwonyango okanye xa utshintsho lwenzululwazi lwenziwe.
Izigulane kufuneka zijongwe kwakhona iimpawu ezifana nokuxhalaba, ukuphazamiseka, ukungabikho kokuzithemba, ukuhlaselwa kwesifo, ukungazinzi, ukunyanzeliswa, ubundlobongela, ukunyaniseka, i-hypomania kunye ne-mania. Ukuba iimpawu ezinjalo zinzima, zenzeke ngokukhawuleza okanye zazingekho iimpawu ezazikhona phambi kokuba unyango luqale, kufuneka kuqwalaselwe ukuguqula isigulane kwiyeza ezahlukeneyo.
Ukusebenzisana kweziyobisi
Ulwazi malunga nokusebenzisana kwezidakamizwa lude kakhulu ukufingqa apha. Nceda uvakashele iwebhusayithi ye-FDA okanye uthethe nogqirha wakho okanye ukhemistri ukuze uthole ulwazi olupheleleyo.
I-Carcinogenesis, i-Mutagenesis, Ukungonakali kobutyebi
Kwiimiceba zowesibini ezifumana amaxesha angama-11 ubuninzi be-dose yomntu ephakanyisiweyo (MRHD), kukho ukunyuka kwi-hepatocellular adenomas ne-carcinomas. I-dose-effect ye-dose yaba ngama-4 ama-MRHD. Isiganeko sokuxhaphaza asizange sinyuswe kwiigundane zesilisa kwiiyitifiketi ukuya kumaxesha angama-8 i-MRHD. Kwakungekho isiganeko kwisifundo esenzelwe kwaye ayizange ithinte i-fertility.
Ukukhulelwa kunye neLactation
I-Cymbalta yiklasi yeClass C. Akukho zifundo ezaneleyo nezilawulwa kakuhle kwabasetyhini abakhulelweyo, ukuze i-duloxetine ifanele isetyenziswe ngexesha lokukhulelwa kuphela ukuba inzuzo enokubangela ukuba ingozi ibe yintsholongwane yomntwana.
Iimpawu Zecala zeCymbalta
Iziganeko eziqhelekileyo eziqhelekileyo, ezichazwe ngaphezulu kwe-5%, zazingcangcazelisi, zomlomo owomileyo, ukuzithemba, ukunciphisa ukutya, ukukhathala, ukulala, nokunyuka.
Iziganeko ezimbi ezenzeka kwi-2% yezigulane zibandakanya uhudo, ukuhlanza, ukulahleka kwesisindo, ukungcola, ukuthuthumela , ukutshisa, ukutshatyalaliswa, ukutshatyalaliswa, ukutshatyalaliswa, ukukhathazeka, kunye neziphumo zesini.
Ukusetyenziswa kakubi kweziyobisi kunye nokuxhomekeka
I-Duloxetine ayikho into elawulwayo. Kwizifundo zezilwanyana, akuzange kubonise ukusetyenziswa kakubi kweziyobisi. Kwizifundo ezixhomekeke kwizidakamizwa, ayizange ibonise ukuveliswa kokuxhomekeka kokuxhomekeka kwimizi. Nangona iCymbalta ingazange ifundwe ngabantu ngendlela yokusetyenziswa kakubi, kwakungekho nqondiso yokuziphatha kwezidakamizwa kwiimvavanyo zeclini.
Isistim nokuLawula
I-Cymbalta kufuneka ilawulwe kwimizuzu yonke yemihla ye-40-60 mg / ngosuku.
Ngokuqhelekileyo, iya kukwahlukana ngamaxabiso amabini athathwe ngamaxesha ahlukeneyo emini. Akuyimfuneko ukuyithatha ngokutya. Akukho bubungqina bokuba amanani angaphezu kwama-60 mg / ngosuku anika nayiphi na inzuzo.
Umthombo:
"Iziqwenga zokuLawulwa kolwazi: I-Cymbalta (Duloxetine Hydrochloride) Iwebhusayithi yokuLawulwa kweeDrama ne-Drug. US Food and Drug Administration. Uhlaziyiweyo: Disemba 4, 2008. Kufumaneka: Disemba 4, 2015.